RxDoctor Payments Data

Joelle Meitl

Psychiatric/Mental Health · Larned, KSNPI 1366068173

Payments from drug & device makers

$1,680in general payments, 2019–2025

Across 102 payments — averaging $16.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vanda Pharmaceuticals Inc.$279
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$265
  • AbbVie$247
  • Teva Pharmaceuticals USA, Inc.$137
  • Alkermes, Inc.$135
  • Johnson & Johnson$97
  • plus $519 from 11 others

What the payments were for

  • Food & beverage$1,680100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,680 in reported general payments places this provider in the 70th percentile of 404 psychiatric/mental health providers in Kansas.

See all psychiatric/mental health providers in Kansas

Medicare billing

Part B allowed, 2024
$32,318
Medicare patients
50
Services billed
645

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate15$50,856
Olanzapine OdtOlanzapine13$7,104
Quetiapine Fumarate52$1,282
Aripiprazole29$1,263
Duloxetine Hcl41$647
Venlafaxine Hcl ErVenlafaxine Hcl51$610
Hydroxyzine Hcl20$596
Oxcarbazepine18$472
Trazodone Hcl47$416
Lamotrigine44$336
Mirtazapine26$322
Quetiapine Fumarate ErQuetiapine Fumarate11$305
Olanzapine26$284
Lurasidone Hcl11$244
Buspirone Hcl15$238

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$97$50,85615 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 404 psychiatric/mental health providers in Kansas.

Other psychiatric/mental health in Larned

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →